ArticleJournal of echocardiography2026
Isolated increases in tricuspid regurgitation velocity during exercise in dyspneic patients without risks for pulmonary hypertension.
Article in Journal of echocardiography, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAn isolated increase in tricuspid regurgitation velocity (TRV) during exercise stress echocardiography is frequently observed in patients with dyspnea, even in the absence of E/e' elevation. However, the pathophysiological and prognostic significance of this finding, particularly in patients without risk factors for pulmonary hypertension (PH), remains uncertain.
methodsPatients who underwent bicycle exercise stress echocardiography with simultaneous expired gas analysis for the evaluation of exertional dyspnea were retrospectively identified. After excluding patients with risk factors for PH, participants were categorized into three groups: controls (exercise TRV ≤ 3.2 m/s and exercise E/e' <15; n = 360), isolated exercise-induced increase in TRV (isolated Ei-TRV, exercise TRV > 3.2 m/s and exercise E/e' <15; n = 83), and heart failure with preserved ejection fraction (HFpEF, exercise E/e' ≥15; n = 211).
resultsPeak oxygen consumption was comparable between isolated Ei-TRV and controls, but significantly reduced in HFpEF. Over a median follow-up of 595 days, HFpEF patients had a two-fold higher risk of all-cause death and worsening HF events compared with controls whereas outcomes in isolated Ei-TRV did not significantly differ from controls. Nearly all patients with isolated Ei-TRV exhibited an abnormally elevated mean pulmonary artery pressure/cardiac output slope (mPAP/CO > 3 mmHg/L/min), and those with slopes > 5.2 mmHg/L/min had reduced peak oxygen consumption compared with those with slope ≤ 5.2 mmHg/L/min.
conclusionsIn dyspneic patients without apparent risks for PH, isolated Ei-TRV was associated with preserved exercise capacity, without increased adverse outcomes compared with controls. Assessment of mPAP/CO slope may help refine risk stratification compared to exercise TRV alone in this population.
Indexed as
Identifiers
42400760What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.